Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREX-DME: Ranibizumab Treat and Extend in Diabetic Macular Edema
NCT01934556Phase 2Completed
- Sponsor
- Palmetto Retina Center
- Start
- Nov 2013
- Primary completion
- Apr 2017
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in diabetic macular edema (DME), sponsored by Palmetto Retina Center. Started Nov 2013; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01934556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01934556.